*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R9720 | Elevated prostate specific antigen [PSA] | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R9720 | Elevated prostate specific antigen [PSA] | 5.15 | 16.82 | ||||||||||||||||
R972 | Elevated prostate specific antigen [PSA] | 5.27 | 17.56 | ||||||||||||||||
R9721 | Rising PSA following treatment for malignant neoplasm of prostate | 5.01 | 20.83 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,808,415 | ||||
Total Hospitalizations with ICD R972 - Elevated prostate specific antigen [PSA] | 335 | ||||
DRG Share of Total Hospitalizations | 5.5 | ||||
% of Total ICD R972 - Elevated prostate specific antigen [PSA] in DRG | 2.11 | ||||
Avg LOS at DRG | 6.34 | ||||
Avg LOS with ICD R972 - Elevated prostate specific antigen [PSA] | 6.57 | ||||
Readmission Rate at DRG | 24.2 | ||||
Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 20.9 | ||||
Unplanned Readmission Rate at DRG | 16.78 | ||||
Unplanned Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 11.58 | ||||
Total Medicare payments at DRG | $21,288,214,047 | ||||
Total Medicare payments with ICD R972 - Elevated prostate specific antigen [PSA] | $3,849,698 | ||||
Total Medicare payment per Day at DRG | $1,857 | ||||
Total Medicare payment per Day with ICD R972 - Elevated prostate specific antigen [PSA] | $1,748 | ||||
Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
Total Medicare payment per Hospitalization with ICD R972 - Elevated prostate specific antigen [PSA] | $11,492 | ||||
Total Medicare Charges at DRG | $107,155,481,388 | ||||
Total Medicare Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $18,974,184 | ||||
Avg Charges at DRG | $59,254 | ||||
Avg Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $56,639 | ||||
Mortality Rate at DRG | 12.11 | ||||
Mortality Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 5.37 | ||||
SNF Discharge Rate at DRG | 27.18 | ||||
SNF Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 28.96 | ||||
Home Discharge Rate at DRG | 25.81 | ||||
Home Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 32.54 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 713: TRANSURETHRAL PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 17,330 | ||||
Total Hospitalizations with ICD R972 - Elevated prostate specific antigen [PSA] | 144 | ||||
DRG Share of Total Hospitalizations | 0.05 | ||||
% of Total ICD R972 - Elevated prostate specific antigen [PSA] in DRG | 0.91 | ||||
Avg LOS at DRG | 3.88 | ||||
Avg LOS with ICD R972 - Elevated prostate specific antigen [PSA] | 3.42 | ||||
Readmission Rate at DRG | 14.79 | ||||
Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 12.5 | ||||
Unplanned Readmission Rate at DRG | 11.24 | ||||
Unplanned Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 9.03 | ||||
Total Medicare payments at DRG | $155,091,532 | ||||
Total Medicare payments with ICD R972 - Elevated prostate specific antigen [PSA] | $1,247,413 | ||||
Total Medicare payment per Day at DRG | $2,304 | ||||
Total Medicare payment per Day with ICD R972 - Elevated prostate specific antigen [PSA] | $2,535 | ||||
Total Medicare payment per Hospitalization at DRG | $8,949 | ||||
Total Medicare payment per Hospitalization with ICD R972 - Elevated prostate specific antigen [PSA] | $8,663 | ||||
Total Medicare Charges at DRG | $834,175,007 | ||||
Total Medicare Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $6,731,283 | ||||
Avg Charges at DRG | $48,135 | ||||
Avg Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $46,745 | ||||
Mortality Rate at DRG | 0.48 | ||||
Mortality Rate with ICD R972 - Elevated prostate specific antigen [PSA] | NA | ||||
SNF Discharge Rate at DRG | 11.4 | ||||
SNF Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 7.64 | ||||
Home Discharge Rate at DRG | 70.23 | ||||
Home Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 84.03 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 862: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 417,755 | ||||
Total Hospitalizations with ICD R972 - Elevated prostate specific antigen [PSA] | 99 | ||||
DRG Share of Total Hospitalizations | 1.27 | ||||
% of Total ICD R972 - Elevated prostate specific antigen [PSA] in DRG | 0.62 | ||||
Avg LOS at DRG | 3.9 | ||||
Avg LOS with ICD R972 - Elevated prostate specific antigen [PSA] | 5.17 | ||||
Readmission Rate at DRG | 16.53 | ||||
Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 12.37 | ||||
Unplanned Readmission Rate at DRG | 11.52 | ||||
Unplanned Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | NA | ||||
Total Medicare payments at DRG | $2,493,587,688 | ||||
Total Medicare payments with ICD R972 - Elevated prostate specific antigen [PSA] | $631,086 | ||||
Total Medicare payment per Day at DRG | $1,529 | ||||
Total Medicare payment per Day with ICD R972 - Elevated prostate specific antigen [PSA] | $1,233 | ||||
Total Medicare payment per Hospitalization at DRG | $5,969 | ||||
Total Medicare payment per Hospitalization with ICD R972 - Elevated prostate specific antigen [PSA] | $6,375 | ||||
Total Medicare Charges at DRG | $11,318,800,289 | ||||
Total Medicare Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $2,960,623 | ||||
Avg Charges at DRG | $27,094 | ||||
Avg Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $29,905 | ||||
Mortality Rate at DRG | 0.87 | ||||
Mortality Rate with ICD R972 - Elevated prostate specific antigen [PSA] | NA | ||||
SNF Discharge Rate at DRG | 17.03 | ||||
SNF Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 13.13 | ||||
Home Discharge Rate at DRG | 53.31 | ||||
Home Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 59.6 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 726: BENIGN PROSTATIC HYPERTROPHY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 714: TRANSURETHRAL PROSTATECTOMY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 15,072 | ||||
Total Hospitalizations with ICD R972 - Elevated prostate specific antigen [PSA] | 80 | ||||
DRG Share of Total Hospitalizations | 0.05 | ||||
% of Total ICD R972 - Elevated prostate specific antigen [PSA] in DRG | 0.5 | ||||
Avg LOS at DRG | 3.21 | ||||
Avg LOS with ICD R972 - Elevated prostate specific antigen [PSA] | 3.46 | ||||
Readmission Rate at DRG | 8.39 | ||||
Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | NA | ||||
Unplanned Readmission Rate at DRG | 6.2 | ||||
Unplanned Readmission Rate with ICD R972 - Elevated prostate specific antigen [PSA] | NA | ||||
Total Medicare payments at DRG | $167,045,654 | ||||
Total Medicare payments with ICD R972 - Elevated prostate specific antigen [PSA] | $852,849 | ||||
Total Medicare payment per Day at DRG | $3,449 | ||||
Total Medicare payment per Day with ICD R972 - Elevated prostate specific antigen [PSA] | $3,079 | ||||
Total Medicare payment per Hospitalization at DRG | $11,083 | ||||
Total Medicare payment per Hospitalization with ICD R972 - Elevated prostate specific antigen [PSA] | $10,661 | ||||
Total Medicare Charges at DRG | $1,066,832,463 | ||||
Total Medicare Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $5,525,489 | ||||
Avg Charges at DRG | $70,782 | ||||
Avg Charges with ICD R972 - Elevated prostate specific antigen [PSA] | $69,069 | ||||
Mortality Rate at DRG | 0.23 | ||||
Mortality Rate with ICD R972 - Elevated prostate specific antigen [PSA] | NA | ||||
SNF Discharge Rate at DRG | 2.81 | ||||
SNF Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | NA | ||||
Home Discharge Rate at DRG | 84.9 | ||||
Home Discharge Rate with ICD R972 - Elevated prostate specific antigen [PSA] | 87.5 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
GLENDALE ADVENTIST MEDICAL CENTER | 1509 WILSON TER | GLENDALE | CA | 91206 | 37 |
LAHEY HOSPITAL & MEDICAL CENTER | 41 MALL RD | BURLINGTON | MA | 01805 | 31 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 31 |